✦ LIBER ✦

O-021 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

✍ Scribed by Falantes, J.; Calderón, C.; Márquez-Malaver, F.J.; Aguilar, M.; Martino, M.L.; González, J.; Montero, M.I.; Parody, R.; Espigado, I.; Pérez-Simón, J.A.

Book ID: 122656554
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 69 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70043-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns of Infection in Patients With M

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

✍ Falantes, Jose F.; Calderón, Cristina; Márquez-Malaver, Francisco J.; Aguilar-Gu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 291 KB

P-301 Results of 5-azacitidine therapy i

P-301 Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)

✍ Freyrie, A.; Reda, G.; Vincenti, D.; Ferla, V.; Orofino, N.; Sciumè, M.; Guidott 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 86 KB

The incidence of invasive fungal infecti

The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole

✍ Barreto, Jason N.; Beach, Cassidy L.; Wolf, Robert C.; Merten, Julianna A.; Tosh 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

A multicenter, randomized trial of posac

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs) in neutropenic patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) receiving intensive chemotherapy

✍ D.J. Winston; O.A. Cornely; J. Maertens; J. Perfect; D. Helfgott; A.J. Ullmann; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A Phase I/II Trial of Combination of PKC

A Phase I/II Trial of Combination of PKC412 and 5-azacytidine (AZA) for the Treatment of Patients with Refractory or Relapsed (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

✍ Nazha, Aziz; Kantarjian, Hagop; Borthakur, Gautam; Kadia, Tapan; Faderl, Stefan; 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 76 KB